Who are we?
Nanopharmacia Group, is integrated by a cluster of interconnected organizations from the professional health investigation field.
With the help of a great disciplinary group of researchers and professionals in the field, we have been able to strengthen and improve overall health by introducing applied nanotechnology. By applying this molecular tool we can ensure that the nutrients on the supplements are absorbed in the best way possible, as well as remaining activated for a longer period of time and reducing any possible side effects.
DR. HORACIO ASTUDILLO DE LA VEGA
Renounced surgeon and midwife, with a masters in Genetics and Molecular Biology and a Science PhD in Molecular Biology.
Dr. Astudillo is the founder of Nanopharmacia and the one in charge of scientific direction. From the beginning, his objective has been to provide people with accessibility and the necessary tools for good preventive health. He is a key asset for the research department in Mexico and for the creation of nanotechnology based products.
Mission
Nanopharmacia Group is an organization dedicated to health service through genomic diagnosis, generation and production of nutraceuticals and medical devices. We are interested in the commitment, development and motivation of our human resources and we offer patients, doctors and institutions only quality services and products safely approved by our team of researchers and professionals through technology.
Vision
We aim to be recognized as one of the leading organizations in diagnosis, products and services of great specialty, precision and innovation in the analysis and testing of molecular biology and medical treatment with human sense and personalization.
Values
Innovation and Research
To be able to always offer the most advanced tests of the market and perform more accurate and prompt diagnosis.
Professionalism
We have a team of professionals highly capacitated to provide the best service.
Excellence
In the performance of our tests, delivery of diagnosis, as well as the selection of the active substances of our products.
Improve quality of life
By incorporating products with the best quality available in the market.
Personalized treatment
To be able to solve any doubt that may be raised during the process.
Ethics and Integrity
In the process of testing and diagnosing to achieve the best personalized treatment.
Development of Professionals
Committed to their development, in genetic innovation and nanotechnology, to whom may propose new solutions and alternatives.
Optimization
In the waiting time of their precise diagnosis and the correct investment on their treatment.
Research
+ 10yrs of research and studies in nanotechnology with renounced clinical experience and extensive preclinical studies.
Evaluations
Evaluated in in-vitro models (toxicity trials) PEI-CONACYT 2015.
Evaluated in in-vivo models (toxicity trials and laboratory trials) PEI-CONACYT 2016.
Research Project Clinical Experience. PEI-CONACYT 2017.
Patents
24 patents have been granted to our products.
